CCL16 and hepatocellular carcinoma: Recent reports also unveil the role of PI3K-AKT-SELE/VCAM1 axis and CCL16-CCR1 axis in TAM recruitment in pancreatic ductal adenocarcinoma (PDAC) and hepatocellular carcinoma (HCC) respectively [41, 42].